EMBO Workshop: Proteostasis shaping health span: from protein folding to failure
This EMBO Workshop examines how protein synthesis, folding, trafficking, and degradation shape health across the lifespan, connecting fundamental proteostasis mechanisms with ageing and degenerative disease.
Studying the Demographic Consequences of Medical Progress
Join Marcus Ebeling’s Medical Demography Group to study how medical progress changes disease burden, ageing and population vulnerability. Themes include the distinction between disease presence and impact, diffusion of medical advances, and population resilience. Postdocs contribute to the shared programme while developing an independent research direction, with collaboration across demography, medicine and epidemiology. This vacancy belongs to the September 2026 Max Planck Postdoc Program call, which accepts applications until 13 October 2026 at 12:00 CEST through the official application platform.
Audio long read: Could mending damaged DNA prolong life?
An audio feature examining research on DNA damage, repair and ageing. The episode explores evidence that inadequate repair contributes to age-related biological changes, and scientific efforts to test whether improving repair can extend healthy life. Nature published this episode on 2 September 2026.
Briefing Chat: Is DNA repair the secret to a long life?
Nature staff discuss evidence from whales and mole rats suggesting that DNA repair may contribute to longevity, and how COVID-19 can reactivate dormant viruses.
Physical Activity, Sedentary Behaviour and Brain Health
How do visual abilities relate to each other?
In vision, there is, surprisingly, very little evidence of common factors. Most studies have found only weak correlations between performance in different visual tests; meaning that, a participant performing better in one test is not more likely to perform also better in another test. Likewise in ageing, cross-sectional studies have repeatedly shown that older adults show deteriorated performance in most visual tests compared to young adults. However, within the older population, there is no evidence for a common factor underlying visual abilities. To investigate further the decline of visual abilities, we performed a longitudinal study with a battery of nine visual tasks three times, with two re-tests after about 4 and 7 years. Most visual abilities are rather stable across 7 years, but not visual acuity. I will discuss possible causes of these paradoxical outcomes.
Taking the pulse of ageing: the role of cerebrovascular risk factors in ageing and dementia
Cerebrovascular support is critical for healthy cognitive ageing. Reduced cerebral blood flow in ageing is caused, among other things, by hypertension, arteriosclerosis (i.e. stiffening of the arteries) and plaque formation. Arterial stiffness is predictive of cognitive decline, is a critical risk factor for cerebrovascular accidents, and has been linked to heightened risks for Alzheimer’s Disease and other forms of dementia. The elasticity of cerebral arteries is influenced by lifestyle factors, including cardiorespiratory fitness. Monica will discuss data obtained in their laboratory with new noninvasive measures of cerebrovascular health (pulse-DOT, a diffuse optical tomographic method for studying cerebral arteriosclerosis), in conjunction with structural and functional brain measures and cognitive assessments. These findings support a model in which localised changes in arteriosclerosis lead to specific profiles of structural, functional, and cognitive declines, paving a way to individualised interventions.
What happens to our ability to perceive multisensory information as we age?
Our ability to perceive the world around us can be affected by a number of factors including the nature of the external information, prior experience of the environment, and the integrity of the underlying perceptual system. A particular challenge for the brain is to maintain a coherent perception from information encoded by the peripheral sensory organs whose function is affected by typical, developmental changes across the lifespan. Yet, how the brain adapts to the maturation of the senses, as well as experiential changes in the multisensory environment, is poorly understood. Over the past few years, we have used a range of multisensory tasks to investigate the role of ageing on the brain’s ability to merge sensory inputs. In particular, we have embedded an audio-visual task based on the sound-induced flash illusion (SIFI) into a large-scale, longitudinal study of ageing. Our findings support the idea that the temporal binding window (TBW) is modulated by age and reveal important individual differences in this TBW that may have clinical implications. However, our investigations also suggest the TWB is experience-dependent with evidence for both long and short term behavioural plasticity. An overview of these findings, including recent evidence on how multisensory integration may be associated with higher order functions, will be discussed.
Why we all need a good night’s sleep
We seek to determine how circadian rhythms and sleep are integrated with physiological processes to provide optimal fitness and health. Using initially a Drosophila model, and more recently also mammalian models, we have found that aspects of the blood brain barrier (BBB) are controlled by the circadian clock. BBB properties are also influenced by sleep:wake state in Drosophila, and, in fact, appear to be contribute to functions of sleep. This and other work, which implicates sleep in the regulation of metabolic processes, is providing insights into sleep function
Multimorbidity in the ageing human brain: lessons from neuropathological assessment
Age-associated dementias are neuropathologically characterized by the identification of hallmark intracellular and extracellular deposition of proteins, i.e., hyperphosphorylated-tau, amyloid-β, and α-synuclein, or cerebrovascular lesions. The neuropathological assessment and staging of these pathologies allows for a diagnosis of a distinct disease, e.g., amyloid-β plaques and hyperphosphorylated tau pathology in Alzheimer's disease. Neuropathological assessment in large scale cohorts, such as the UK’s Brains for Dementia Research (BDR) programme, has made it increasingly clear that the ageing brain is characterized by the presence of multiple age-associated pathologies rather than just the ‘pure’ hallmark lesion as commonly perceived. These additional pathologies can range from low/intermediate levels, that are assumed to have little if any clinical significance, to a full-blown mixed disease where there is the presence of two distinct diseases. In our recent paper (McAleese et al. 2021 Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia, https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12291, Alzheimer's & Dementia), using the BDR cohort, we investigated the frequency of multimorbidity and specifically investigated the impact of additional low-level pathology on cognition. In this study, of 670 donated post-mortem brains, we found that almost 70% of cases exhibited multimorbidity and only 22% were considered a pure diagnosis. Importantly, no case of Lewy Body dementia or vascular dementia was considered pure. A key finding is that the presence of low levels of additional pathology increased the likelihood of having mild dementia vs mild cognitive impairment by almost 20-fold, indicating low levels of additional pathology do impact the clinical progression of a distinct disease. Given the high prevalence and the potential clinical impact, cerebral multimorbidity should be at the forefront of consideration in dementia research.
Population studies and ageing brains, in a time of COVID
This presentation will include a brief resume of research in older populations led from Cambridge that have informed current clinical understanding and policy regarding services and prevention for and of dementia. These population studies have more recently been ‘re-purposed’ with enthusiasm from participants into a trial platform, and this also has enabled ongoing follow-up by telephone during the COVID pandemic. Although there are no formal outputs from these latter developments general impressions will be shared.
Towards resolving the Protein Paradox in longevity and late-life health
Reducing protein intake (and that of key amino acids) extends lifespan, especially during mid-life and early late-life. Yet, due to a powerful protein appetite, reducing protein in the diet leads to increased food intake, promoting obesity – which shortens lifespan. That is the protein paradox. In the talk I will bring together pieces of the jigsaw, including: specific nutrient appetites, protein leverage, macronutrient interactions on appetite and ageing, the role of branched-chain amino acids and FGF-21, and then I will conclude by showing how these pieces fit together and play out in the modern industrialised food environment to result in the global pandemic of obesity and metabolic disease.